Correct use and dosage adjustment recommendations for pesolimab (spesolimab-sbzo)

Pesolimab (spesolimab-sbzo) is an innovative biologic specifically designed to treat generalized pustular psoriasis (GPP) in adults. GPP is a rare and severe skin disease in which widespread erythema and sterile pustules suddenly appear on the patient's skin, accompanied by severe pain and systemic symptoms, seriously affecting the patient's daily life. By specifically blocking the activation of IL-36 receptor (IL-36R), pesolizumab effectively inhibits the abnormal inflammatory response associated with the onset of GPP, bringing new treatment hope to patients.

Correct administration and dosage adjustment are critical when using pessolimab. For patients with acute episodes of GPP, pesolizumab is usually administered as a single 900 mg dose, diluted by intravenous infusion. To ensure the effectiveness and safety of the drug, it is recommended that a single 900 mg dose be infused over 90 minutes. If relapse symptoms persist, an additional 900 mg dose may be considered within one week of the first dose.

For patients requiring long-term maintenance therapy, the administration of pesolizumab may vary. Specifically, doctors will develop a personalized treatment plan based on the patient's specific situation and disease progression. In some cases, subcutaneous injection may be required, and the dose and frequency of administration may be appropriately adjusted based on the patient's weight, age, liver and kidney function and other factors.

It is worth noting that the dosage adjustment of pesolizumab should be carried out under the guidance of a doctor, and patients should not change the dosage or administration method on their own. At the same time, while using pesolimab, patients need to closely monitor their physical condition and report any discomfort or abnormal reactions to their doctor in a timely manner.

In summary, pesolizumab provides a new and effective treatment option for patients with GPP. However, correct usage and dosage adjustment are key to ensuring drug efficacy and safety. Therefore, patients should consult their doctor in detail before use to understand the correct use of the drug, dosage adjustment recommendations, possible side effects and other information in order to better manage their disease.

Reference materials：https://www.drugs.com/spevigo.html